Time and Venue: July 22-27, 2018, Smithfield, Rhode Island, United States
About: The 2018 Gordon Research Conference on Drug Resistance will build on the success of the three prior meetings to focus on assembling a multi-disciplinary group of basic and clinical scientists to understand mechanisms of drug resistance and how to identify and to overcome them using novel strategies.
Drug resistance is a major challenge for the effectiveness of therapies in cancer and infectious diseases and for agricultural products including herbicides and pesticides. Drug resistance negatively impacts the health of millions in both developed and developing nations and has a massive financial impact on society. Despite the common issues facing these fields there are no forums that encourage cross-disciplinary interaction on this important problem. This forum will serve a unique and critical role of bringing together experts from different disciplines to create a community which will share expertise around drug resistance and work together on effective long-term solutions. The community will explore areas including identifying resistance mechanisms, computational modeling of resistance from cells to humans, the use of diagnostics to identify and monitor resistance and the development of novel treatments. Beyond science, the community will become a valuable expert resource for policy makers to develop and guide implementation of effective long-term strategies.
The meeting will assemble a broad group from a diverse area of disciplines including established experts, young investigators and students with wide geographic and cultural perspective to build a long-term community. This will include representation from academic, biotech/pharma and government. The meeting will encourage cutting edge-research presentations coupled with significant discussions and will also provide an opportunity for students to highlight research through poster presentations with the opportunity of a select group of students to present short oral presentations.
Time and Venue: July 29 – August 3, 2018, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
About: Precision medicine has grown to rest on three overarching themes – classify disease more precisely, treat patients on individual scale, and guide public prevention measures. Perhaps we have witnessed no greater progress in precision medicine than in oncology and cancer research. In this meeting description, we highlight recent advances and future perspectives on three major disciplines of cancer research: drug discovery, cancer biomarker development, and "omic" technologies.
Time and Venue: September 10-12, 2018, University of Kent, Canterbury, United Kingdom
About: Despite substantial improvements in recent decades, the prognosis for those cancer patients who suffer from metastatic disease and depend on systemic drug therapy remains poor. Both intrinsic resistance and the formation of acquired drug resistance substantially affects the efficacy of cancer drugs. The advancement of precision medicine approaches holds promise for both the effective guidance of therapies to patients that will respond and the ability to monitor this tumour response. This will require the successful interpretation of "omics" data and a close collaboration between pre-clinical researchers, clinicians, and computational biologists in both academia and industry to develop these strategies. This conference will bring together and showcase cancer researchers from these areas, who will present and discuss the latest advances in understanding the mechanisms of drug resistance in cancer, the identification of biomarkers of drug sensitivity/resistance and how they can be linked to precision medicine approaches.